Offering

Medicines

At the center of our portfolio stand medicines designed to treat type 2 diabetes and complications accompanying this disease. We also offer medicines for the treatment of opioid-induced constipation, breakthrough pain and the treatment and prophylaxis of thromboembolic disease.

Pioglitazone Accord

pioglitazone

Medicine from the group of thiazolidinediones, oral antidiabetic, treatment of type 2 diabetes mellitus, treatment of hyperglycemia, in the form of tablets.

Repaglinide Accord

repaglinide

Medicine from the glinides group, oral antidiabetic, treatment of type 2 diabetes mellitus, treatment of postprandial glycemia, in the form of tablets.